Tissue-engineered bone regeneration

By H. Petite, V. Viateau, W. Bensaïd, A. Meunier, C. D. Pollak, M. Bourguignon, K. Oudina, L. Sedel, G. Guillemin. Nature Biotechnology, 2000

1,494 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Epidemiology, Genetics

View Paper: https://www.semanticscholar.org/paper/eb6ef2acd61d80750cbd1bb5a513ef4e843b5dab

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biomedical Engineering

1. Rui Luís Reis
2. Dietmar Werner Hutmacher
3. A. Salgado
4. C. Lam
5. T. Lim
6. H. Tan
7. K. C. Tan
8. J. Schantz

In Genetics

1. Rocky S. Tuan
2. L. Song
3. D. Baksh
4. Elizabeth Cho
5. Catherine M. Kolf

Citations in the corpus

• State of the art and future directions of scaffold‐based bone engineering from a biomaterials perspective (2007, background): “Transcortical bony defects implanted with coral become vascularized and are invaded by newly formed bone, whereas the coral is resorbed at a rate commensurate with bone formation (Petite et al., 2000).”
• Alginate-Based Biomaterials for Regenerative Medicine Applications (2013, background): “They can be applied as delivery vehicles for bioactive molecules, and as three-dimensional structures that organize cells, serving as a temporary skeleton to accommodate and stimulate new tissue growth [90,91].”
• Mesenchymal stem cell homing: the devil is in the details. (2009, neutral): “Although local transplantation or injection of MSCs represents a potential approach that may be useful in certain settings (Bantubungi et al., 2008; Petite et al., 2000), the potential for minimally invasive delivery of MSCs via systemic infusion is of particular interest (Lee et al., 2008;…”
• Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy (2004, background): “MSCs are considered a readily accepted source of stem cells because such cells have already demonstrated efficacy in multiple types of cellular therapeutic strategies, including applications in treating children with osteogenesis imperfecta [1], hematopoietic recovery [2], and bone tissue regenerati”
• Bone tissue engineering: state of the art and future trends. (2004, methodology): “Allograft bone also introduces the possibilities of immune rejection and of pathogen transmission from donor to host, and although infrequent, infections could occur in the recipient’s body due to the transplantation [30-34,37].”